Noxxon Pharma AG
Executive Summary
Every living organism is made out of chemicals, including proteins and nucleic acids, which use one chiral form; that is, they are either "left-handed" or "right-handed." It is this molecular design that allows the chemicals to perform precise biological functions. Noxxon's technology exploits this "handedness" by creating mirror-image molecules it calls spiegelmers (based on the German word for mirror, spiegel) by evolutionary design that bind tightly and specifically to known biological targets.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.